Fulminant Myocarditis with Combination Immune Checkpoint Blockade | NEJM
Immune checkpoint inhibitors have improved clinical outcomes associated with numerous cancers, but high-grade, immune-related adverse events can occur, particularly with combination immunotherapy. ...
nejm.org